Jeil Pharmaceutical Co Ltd Long-term Investment Intensity

Latest as of September 2019: 0.2%

Jeil Pharmaceutical Co Ltd long-term investment intensity. Jeil Pharmaceutical Co Ltd (271980) has a Long-term Investment Intensity of 0.2% as of September 2019. Long-term investments of ₩962.66 Million represent 0.2% of total assets of ₩401.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Jeil Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

LT Investment Intensity

0.2%
LT Investments / Total Assets

Long-term Investments

₩962.66 Million
KRW

Total Assets

₩401.59 Billion
KRW

Country

Korea
KO

Long-term Investment Intensity of Jeil Pharmaceutical Co Ltd (2017–2018)

Long-term investment intensity of Jeil Pharmaceutical Co Ltd from 2017 to 2018. This chart shows how Jeil Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 0.2%, reflecting long-term investments of ₩962.66 Million against total assets of ₩401.59 Billion KRW.

Jeil Pharmaceutical Co Ltd Long-term Investment Intensity by Year (2017–2018)

Jeil Pharmaceutical Co Ltd long-term investment intensity by year from 2017 to 2018. The table below presents the year-by-year Long-term Investment Intensity for Jeil Pharmaceutical Co Ltd from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 271980 total assets.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 0.2% ₩977.95 Million ₩402.90 Billion ▼ -0.5 pp
2017 0.7% ₩3.03 Billion ₩413.73 Billion —
pp = percentage points